ImmunoGen Message Board - Msg: 14839264

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sonny who wrote (3721)	11/18/2000 12:16:45 PM
From: RJMC	Read Replies (2) of 5665

The latest MTSL Stock Letter changed Immunogen from a buy under $20 to a hold. Looks like they are finally reassessing where Immunogen should be. They had a brief discussion on the reports from the AACR meeting and talked about the secondary offering. There were two companies that MTSL placed as a hold. Immunogen and NPS Pharmaceuticals. NPS just finished with a secondary offering. Upon completion of the secondary offering the NPS stock went up over $7 a share! Don't doubt that Immunogen may do the same once the 4,000,000 shares and over allotments, if any, have been placed. MTSL is waiting for the dust to settle before they initiate new buy recommendations on NPS and Immunogen. Bob M. P.S. If any of you are interested in subscribing to the MTSL stock letter, just contact them at www.bioinvest.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next